Compare CUZ & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUZ | INDV |
|---|---|---|
| Founded | 1958 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.1B |
| IPO Year | N/A | N/A |
| Metric | CUZ | INDV |
|---|---|---|
| Price | $24.80 | $35.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $31.55 | ★ $32.50 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | ★ 5.19% | N/A |
| EPS Growth | ★ 3.48 | N/A |
| EPS | 0.35 | ★ 0.98 |
| Revenue | $955,949,000.00 | ★ $1,180,000,000.00 |
| Revenue This Year | $14.95 | $1.09 |
| Revenue Next Year | $2.68 | N/A |
| P/E Ratio | $71.11 | ★ $35.79 |
| Revenue Growth | ★ 15.46 | N/A |
| 52 Week Low | $24.07 | $7.62 |
| 52 Week High | $31.66 | $35.31 |
| Indicator | CUZ | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 34.22 | 78.45 |
| Support Level | $25.33 | $33.50 |
| Resistance Level | $25.82 | $33.64 |
| Average True Range (ATR) | 0.53 | 1.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 2.13 | 96.36 |
Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.